Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60005 |
CK1-IN-3
|
Casein Kinase | Metabolism; Stem Cells |
CK1-IN-3 是酪蛋白激酶 1 抑制剂,可用于治疗或预防与 circadiantiazol 节律相关的疾病、炎症性疾病的研究。 | |||
T5393 |
CK1-IN-1
PUN51207 |
p38 MAPK; Casein Kinase | MAPK; Metabolism; Stem Cells |
CK1-IN-1 (PUN51207) 是一种酪蛋白激酶 1 抑制剂,对 CK1δ、CK1ε和p38σ MAPK 的IC50值为 15 nM、16 nM 和73 nM。 | |||
T79145 |
CK1-IN-2
|
Casein Kinase | Metabolism; Stem Cells |
CK1-IN-2 (compound Nr.4) 作为CK1抑制剂展现出高效性,其对CK1a、CK1d、CK1e、p38a的IC50值依次为123、19.8、26.8、74.3 nM。 | |||
T9175 |
Casein Kinase inhibitor A51
|
Apoptosis; Casein Kinase | Apoptosis; Metabolism; Stem Cells |
Casein Kinase inhibitor A51 是一种具有口服活性的酪蛋白激酶 1α (CK1α) 抑制剂,具有抗癌活性,可诱导白血病细胞凋亡 (apoptosis),可用于研究颈部癌、急性髓系白血病、乳腺癌和前列腺癌。 | |||
T8987 |
Epiblastin A
|
Casein Kinase | Metabolism; Stem Cells |
Epiblastin A 是 ATP 竞争性的酪蛋白激酶 1 (CK1) 抑制剂,能够抑制 CK1α (IC50:8.9 µM)、 CK1δ (IC50:0.5 µM)、CK1 ɛ (IC50:4.7 µM)。它能够抑制 CK1 诱导外胚层干细胞重编程为胚胎干细胞。 | |||
T22884 |
JW 67
|
Wnt/beta-catenin | Cytoskeletal Signaling; Stem Cells |
JW 67 是典型 Wnt 信号通路的抑制剂,IC50为 1.17 μM。它影响由 β- 连环蛋白/GSK-3β/AXIN/APC/CK1 组成的多蛋白复合物,快速降低活性 β- 连环蛋白,随后下调Wnt 靶基因。它也抑制结直肠癌细胞生长。 | |||
T19913 |
CKI-7
CKI 7 2HCl,CKI-7 dihydrochloride,N-(2-氨基乙基)-5-氯异喹啉-8-磺酰胺二盐酸盐,CKI7 2HCl,CKI 7 dihydrochloride,CKI7 dihydrochloride,CKI-7 2HCl |
ROCK; SGK; Casein Kinase; CDK; S6 Kinase | Cell Cycle/Checkpoint; Cytoskeletal Signaling; MAPK; Metabolism; PI3K/Akt/mTOR signaling; Stem Cells |
CKI-7 是一种有效且 ATP 竞争性的酪蛋白激酶 1 抑制剂,IC50为 6 μM,Ki 为 8.5 μM。它选择性抑制 Cdc7激酶,还抑制 SGK,S6K1以及 MSK1。 | |||
TP1971 |
Pseudo RACK1
|
||
Activator of protein kinase C; attached to cell permeabilization Antennapedia domain vector peptide. Consists of peptide derived from the C2 domain of PKC β linked by a disulfide bridge to the Antennapedia domain vector peptide. The Antennapedia peptide i | |||
T61843 | CK156 | ||
CK156 is a potent inhibitor of death-associated protein kinase (DAPK), demonstrating high selectivity. In the DRAK1 NanoBRET assay, CK156 exhibits IC50 values of 182 nM, 34 μM, and 39 μM for DRAK1, CK2a1, and CK2a2, respectively. This compound is valuable for studying autoimmune and inflammatory diseases [1]. | |||
T71654 |
APcK110
|
||
APcK110 is a novel Kit inhibitor . APcK110 inhibits proliferation of the mastocytosis cell line HMC1.2 and the SCF-responsive cell line OCI/AML3 in a dose-dependent manner . APcK110 is a more potent inhibitor of OCI/AML3 proliferation than the clinically used Kit inhibitors imatinib and dasatinib and at least as potent as cytarabine. APcK110 inhibits the phosphorylation of Kit, Stat3, Stat5, and Akt in a dose-dependent fashion, showing activity of APcK110 on Kit and its downstream signaling path... | |||
T27030 |
CK176
HIV-1 inhibitor-34,HIV-1 inhibitor 34,CK 176,CK-176,HIV-1 inhibitor34 |
||
CK176 is a capsid targeted inhibitor of HIV-1 replication. CK176 shows an 11-fold improvement over I-XW-053 in blocking HIV-1 replication in primary human peripheral blood mononuclear cells (PBMCs). | |||
T2449 |
D4476
D 4476,Casein Kinase I Inhibitor |
Apoptosis; Casein Kinase; ALK; Autophagy | Angiogenesis; Apoptosis; Autophagy; Metabolism; Stem Cells; Tyrosine Kinase/Adaptors |
D4476 (Casein Kinase I Inhibitor) 是一种选择性和细胞渗透性的CK1抑制剂,在体外实验的IC50值为0.3 μM。 | |||
T2440 |
IC261
SU-5607 |
Apoptosis; Casein Kinase; CDK | Apoptosis; Cell Cycle/Checkpoint; Metabolism; Stem Cells |
IC261 (SU-5607) 是一种选择性的,ATP 竞争性的CK1抑制剂,可触发有丝分裂检查点控制。对Ckiδ、Ckiε、 Ckiα1 和Cdk5的IC50值分别为 1 μM、1 μM 、16 μM 和4.5mM。 | |||
T6745 |
5-Iodotubercidin
5-碘代杀结核菌素,5-ITu,NSC 113939 |
Adenosine Receptor | GPCR/G Protein; Neuroscience |
5-Iodotubercidin (NSC-113939) 是一种 ATP 类似物,有效抑制腺苷激酶,IC50为 26 nM。它可以激活磷酸化酶和糖原合成酶,在离体肝细胞中启动糖原合成。它也抑制 CK1、胰岛素受体酪氨酸激酶、磷酸化酶激酶、PKA、CK2、PKC 和 Haspin 。 | |||
T4645 |
TA-01
|
p38 MAPK; Casein Kinase; Autophagy | Autophagy; MAPK; Metabolism; Stem Cells |
TA01 是一种心源性抑制剂,有效抑制CK1和p38 MAPK,其对 CK1ε,CK1δ 和 p38 MAPK 的IC50值分别为 6.4 nM,6.8 nM 和 6.7 nM。 | |||
T21915 |
TBCA
Casein Kinase II Inhibitor III, TBCA |
Casein Kinase | Metabolism; Stem Cells |
TBCA (Casein Kinase II Inhibitor III, TBCA) 是高选择性的酪蛋白激酶II CK2 抑制剂,IC50 为 110 nM,Ki 为 77 nM。TBCA 对 CK1、DYRK1A 和 其它 27 个激酶表现出选择性。 | |||
T23224 |
(R)-DRF053 dihydrochloride
|
Others | Others |
cdk/CK1 inhibitor,potent and ATP-competitive | |||
T10829 |
CKI-7 free base
CKI-7 |
Casein Kinase | Metabolism; Stem Cells |
CKI-7 free base is a potent and ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor. CKI-7 free base also inhibits SGK, ribosomal S6 kinase-1 (S6K1), and MSK1. | |||
T2695 |
TBB
Casein Kinase II Inhibitor I,NSC 231634,4,5,6,7-tetrabromobenzotriazole |
GSK-3; Casein Kinase; CDK | Cell Cycle/Checkpoint; Metabolism; PI3K/Akt/mTOR signaling; Stem Cells |
TBB (NSC-231634) 是一种高选择性的 ATP/GTP 竞争性酪蛋白激酶 2 (CK2) 抑制剂,可抑制大鼠肝脏 CK2,IC50值为0.15 μM。 | |||
T16141 | MRT00033659 | Others | Others |
MRT00033659 is an effective broad-spectrum kinase inhibitor of CK1 (IC50=0.9 µM for CK1δ) and CHK1 (IC50=0.23 µM). MRT00033659 is a pyrazolo-pyridine analogue. It also induces p53 pathway activation and E2F-1 destabilization. | |||
T83684 |
Myelin Basic Protein Peptide (mouse, bovine) TFA
Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu,MBP Peptide |
||
Myelin基础蛋白(MBP)肽是PKC的肽底物,相比PKA、酪蛋白激酶1(CK1)、CK2、磷酸化酶激酶及钙/钙调蛋白依赖性蛋白激酶(CaMKII),它对PKC有选择性。MBP肽已用于监测原发性人类肾动脉平滑肌细胞中的PKC活性。 | |||
T14069 |
A-3 hydrochloride
|
CaMK; Casein Kinase; PKA; PKC | Chromatin/Epigenetic; Cytoskeletal Signaling; Metabolism; Neuroscience; Stem Cells; Tyrosine Kinase/Adaptors |
A-3 hydrochloride 是一种细胞可渗透的、可逆的、ATP 竞争性非选择性拮抗剂。它抑制 PKA 、酪蛋白激酶 II 和肌球蛋白轻链激酶,Ki 值分别为4.3 µM、5.1 µM 和7.4 µM。它还抑制 PKC 和酪蛋白激酶 I 的活性,Ki 分别为 47 µM 和 80 µM。 | |||
T16507 |
PF-5006739
|
Casein Kinase | Metabolism; Stem Cells |
PF-5006739 is an effective and selective inhibitor of CK1δ/ε (IC50s: 3.9 nM and 17.0 nM, respectively). PF-5006739 is a potential therapeutic agent for a range of psychiatric disorders with low nanomolar in vitro potency for CK1δ/ε and high kinome selecti | |||
T10298L |
AMG-548
|
p38 MAPK | MAPK |
AMG-548 is an orally active and selective p38α inhibitor (Ki=0.5 nM), shows slightly selective over p38β (Ki=36 nM) and >1000 fold selective against p38γ and p38δ and is also extremely potent in the inhibition of whole blood LPS stimulated TNFα (IC50=3 nM |